Tüdőrák: nyitott vizsgálatok itt: Horvátország
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2/3. fázisToborozTrial-stage medicine
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Where
- Grad Zagreb, Rijeka
- Age
- 18 év and over
- People
- 626 worldwide
- Run by
- Mirati Therapeutics Inc.
See details and how to joinNCT04613596EU 2023-508922-83-00Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
- Where
- Dubrovnik, Grad Zagreb, Osijek, Rijeka, Split
- Age
- 18 év and over
- People
- 630 worldwide
- Run by
- Mirati Therapeutics Inc.
See details and how to joinNCT06875310EU 2024-515698-85-00Regiszter frissítve: 2026-10-27
3. fázisToborozResearch participation
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
- Where
- Grad Zagreb
- Age
- 18 év and over
- People
- 263 worldwide
- Run by
- Zai Lab (US) LLC
See details and how to join2025-522818-23-00EU 2025-522818-23-00Regiszter frissítve: 2026-10-19
No phaseToborozResearch participation
Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.
- Where
- Osijek
- Age
- 18 év and over
- People
- 56
- Run by
- Osijek University Hospital
See details and how to joinNCT07393490Regiszter frissítve: 2026-06-26
Minden vizsgálat (Tüdőrák) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.